Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001144204-11-019093
Filing Date
2011-03-31
Accepted
2011-03-31 16:32:11
Documents
11
Period of Report
2010-12-31

Document Format Files

Seq Description Document Type Size
1 v216077_10k.htm 10-K 1358739
2 GRAPHIC pg5.jpg GRAPHIC 60054
3 v216077_ex10-46.htm EX-10.46 18495
4 v216077_ex10-47.htm EX-10.47 32436
5 v216077_ex10-48.htm EX-10.48 31568
6 v216077_ex10-49.htm EX-10.49 12082
7 v216077_ex10-50.htm EX-10.50 161692
8 v216077_ex10-51.htm EX-10.51 45873
9 v216077_ex21-1.htm EX-21.1 5102
10 v216077_ex31-1.htm EX-31.1 14442
11 v216077_ex32-1.htm EX-32.1 9654
  Complete submission text file 0001144204-11-019093.txt   1774071
Mailing Address NO. 6, YUANQUAN ROAD, WUQING NEW-TECH INDUSTRIAL PARK TIANJIN, P.R. F4 301700
Business Address NO. 6, YUANQUAN ROAD, WUQING NEW-TECH INDUSTRIAL PARK TIANJIN, P.R. F4 301700 86 22-82137264
TIENS BIOTECH GROUP USA INC (Filer) CIK: 0001168556 (see all company filings)

EIN.: 752926439
Type: 10-K | Act: 34 | File No.: 001-32477 | Film No.: 11726653
SIC: 2834 Pharmaceutical Preparations